News
Tarsus Prices $100M Public Offering Of 2,812,500 Common Shares At $32/Share
1 Mar 24
News
Tarsus Pharmaceuticals Reveals Proposed $100M Public Offering
29 Feb 24
News, Offerings
A Glimpse Into The Expert Outlook On Tarsus Pharmaceuticals Through 4 Analysts
29 Feb 24
Analyst Ratings
Goldman Sachs Maintains Neutral on Tarsus Pharmaceuticals, Raises Price Target to $30
29 Feb 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Maintains Buy on Tarsus Pharmaceuticals, Raises Price Target to $57
28 Feb 24
News, Price Target, Analyst Ratings
Barclays Maintains Overweight on Tarsus Pharmaceuticals, Raises Price Target to $50
28 Feb 24
News, Price Target, Analyst Ratings
ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday
28 Feb 24
News, Price Target, Small Cap, Markets, Analyst Ratings, Trading Ideas
Oppenheimer Reiterates Outperform on Tarsus Pharmaceuticals, Raises Price Target to $59
28 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Tarsus Pharmaceuticals Q4 EPS $(1.31) Beats $(1.36) Estimate, Sales $13.08M Beat $5.66M Estimate
27 Feb 24
Earnings, News
Earnings Scheduled For February 27, 2024
27 Feb 24
Earnings
Tarsus Pharmaceuticals's Earnings: A Preview
26 Feb 24
Earnings
Press releases
Tarsus Announces Pricing of $100.0 Million Public Offering
1 Mar 24
Press Releases
Tarsus Announces Proposed $100.0 Million Public Offering
29 Feb 24
News, Financing, Press Releases
Thinking about buying stock in Summit Materials, Informatica, Unicycive Therapeutics, Tarsus Pharmaceuticals, or Zion Oil and Gas?
29 Feb 24
Opinion, Press Releases
Tarsus to Report Fourth Quarter and Full Year 2023 Financial Results on Tuesday, February 27, 2024
20 Feb 24
News, Press Releases
Tarsus to Participate in Fireside Chat at the Sixth Annual Guggenheim Healthcare Talks Conference
31 Jan 24
News, Press Releases